Charles Zhu
Stock Analyst at LifeSci Capital
(4.90)
# 203
Out of 4,792 analysts
297
Total ratings
66.8%
Success rate
27.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Charles Zhu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADAG Adagene | Reiterated: Buy | $8 | $3.31 | +141.69% | 10 | Sep 10, 2026 | |
| IDYA IDEAYA Biosciences | Reiterated: Buy | $58 | $37.45 | +54.87% | 57 | Sep 9, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $315 | $203.35 | +54.91% | 33 | Sep 2, 2026 | |
| BLSM BlossomHill Therapeutics | Initiated Coverage: Buy | $32 | $21.51 | +48.77% | 1 | Sep 1, 2026 | |
| MOLN Molecular Partners AG | Reiterated: Buy | $12 | $4.18 | +187.08% | 20 | Aug 25, 2026 | |
| ZYME Zymeworks | Reiterated: Buy | $34 | $26.44 | +28.62% | 29 | Aug 25, 2026 | |
| KURA Kura Oncology | Reiterated: Buy | $28 | $11.57 | +142.01% | 34 | Aug 13, 2026 | |
| PBLS Parabilis Medicines | Reiterated: Buy | $42 | $36.32 | +15.64% | 4 | Aug 13, 2026 | |
| IMNM Immunome | Reiterated: Buy | $40 | $24.97 | +60.19% | 20 | Aug 12, 2026 | |
| STRO Sutro Biopharma | Reiterated: Buy | $54 | $17.83 | +202.86% | 5 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 → $20 | $3.79 | +427.70% | 20 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $2 | $0.3664 | +445.85% | 8 | Aug 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $2.05 | +192.68% | 13 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $26.15 | +75.91% | 3 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $19.46 | +43.88% | 11 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $6.74 | n/a | 1 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $23.37 | n/a | 3 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $20 | $3.97 | n/a | 6 | Jan 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $34.08 | n/a | 4 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $39 | $24.26 | n/a | 4 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.5315 | n/a | 3 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $36.12 | n/a | 3 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $20 | $1.44 | n/a | 4 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2.00 | $0.42 | n/a | 1 | Nov 29, 2022 |
Adagene
Sep 10, 2026
Reiterated: Buy
Price Target: $8
Current: $3.31
Upside: +141.69%
IDEAYA Biosciences
Sep 9, 2026
Reiterated: Buy
Price Target: $58
Current: $37.45
Upside: +54.87%
Revolution Medicines
Sep 2, 2026
Reiterated: Buy
Price Target: $315
Current: $203.35
Upside: +54.91%
BlossomHill Therapeutics
Sep 1, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $21.51
Upside: +48.77%
Molecular Partners AG
Aug 25, 2026
Reiterated: Buy
Price Target: $12
Current: $4.18
Upside: +187.08%
Zymeworks
Aug 25, 2026
Reiterated: Buy
Price Target: $34
Current: $26.44
Upside: +28.62%
Kura Oncology
Aug 13, 2026
Reiterated: Buy
Price Target: $28
Current: $11.57
Upside: +142.01%
Parabilis Medicines
Aug 13, 2026
Reiterated: Buy
Price Target: $42
Current: $36.32
Upside: +15.64%
Immunome
Aug 12, 2026
Reiterated: Buy
Price Target: $40
Current: $24.97
Upside: +60.19%
Sutro Biopharma
Aug 12, 2026
Reiterated: Buy
Price Target: $54
Current: $17.83
Upside: +202.86%
Aug 11, 2026
Rated: Buy
Price Target: $26 → $20
Current: $3.79
Upside: +427.70%
Aug 8, 2026
Downgraded: Hold
Price Target: $6 → $2
Current: $0.3664
Upside: +445.85%
Aug 6, 2026
Reiterated: Buy
Price Target: $6
Current: $2.05
Upside: +192.68%
Aug 5, 2026
Reiterated: Buy
Price Target: $46
Current: $26.15
Upside: +75.91%
Jul 30, 2026
Reiterated: Buy
Price Target: $28
Current: $19.46
Upside: +43.88%
Jun 18, 2025
Initiated Coverage: Buy
Price Target: $22
Current: $6.74
Upside: n/a
May 24, 2024
Reiterated: Buy
Price Target: $14
Current: $23.37
Upside: n/a
Jan 2, 2024
Reiterated: Buy
Price Target: $12 → $20
Current: $3.97
Upside: n/a
Jun 13, 2023
Reiterated: Buy
Price Target: $26
Current: $34.08
Upside: n/a
May 9, 2023
Reiterated: Buy
Price Target: $45 → $39
Current: $24.26
Upside: n/a
Mar 17, 2023
Reiterated: Buy
Price Target: $5
Current: $0.5315
Upside: n/a
Jan 3, 2023
Reiterated: Hold
Price Target: n/a
Current: $36.12
Upside: n/a
Jan 3, 2023
Reiterated: Buy
Price Target: $30 → $20
Current: $1.44
Upside: n/a
Nov 29, 2022
Initiated Coverage: Buy
Price Target: $2.00
Current: $0.42
Upside: n/a